Therapy News and Research

RSS

Use of HIV RNA expression inhibitors restores immune function in HIV patients on cART

Immune activation and inflammation persist in the majority of treated HIV-infected individuals and is associated with excess risk of mortality and morbidity.

28 Aug 2018

UIC receives $7 million for developing programs to prevent adolescent depression

The University of Illinois at Chicago has been awarded $7 million in funding from the Patient-Centered Outcomes Research Institute to develop programs to prevent depression among teens.

27 Aug 2018

Amphetamine regimen does not improve post-stroke motor recovery

A pilot clinical trial exploring the benefit of d-amphetamine combined with physical therapy for stroke patients found no evidence that the regimen improved post-stroke motor recovery.

27 Aug 2018

Study shows new options to lower heart disease risk in people with diabetes

A drug used to manage diabetes may reduce heart disease and death in people with diabetes regardless of their cholesterol levels and whether they are on a statin therapy, suggests a new analysis of the LEADER trial.

27 Aug 2018

New personalized cellular therapy approved for use in the European Union

The European Commission has approved a personalized cellular therapy developed at the University of Pennsylvania's Abramson Cancer Center, making it the first chimeric antigen receptor (CAR) T cell therapy permitted for use in the European Union in two distinct indications.

27 Aug 2018

Antiplatelet monotherapy appears to be safer but does not reduce risk of heart attack

Long-term antiplatelet monotherapy after stenting is safe but does not reduce the risk of death or heart attack compared to standard dual antiplatelet therapy, according to late breaking results from the GLOBAL LEADERS trial presented today in a Hot Line Session at ESC Congress 2018 and published in The Lancet.

27 Aug 2018

Listening to yoga music before sleep has beneficial impact on heart rate variability

Listening to yoga music at bedtime is good for the heart, according to research presented today at ESC Congress 2018.

27 Aug 2018

Antithrombin drug does not reduce risk of myocardial infarction, stroke in heart failure patients

The antithrombin drug rivaroxaban does not reduce the risk of a composite endpoint of survival, myocardial infarction and stroke after an episode of worsening heart failure in patients with heart failure, sinus rhythm, and coronary artery disease, according to late breaking results from the COMMANDER HF trial presented today in a Hot Line Session at ESC Congress 2018 and with simultaneous publication in NEJM.

27 Aug 2018

Death of Sen. John McCain sheds new light on aggressive brain tumor

The death today of Sen. John McCain (R-Ariz.) sheds a new light on glioblastoma, a form of brain cancer that the American Brain Tumor Association estimated would be diagnosed in nearly 13,000 people this year.

27 Aug 2018

Researchers investigate ability of Masimo Ori to show oxygenation trends during moderate hyperoxia

Masimo announced today the findings of a study recently published in Anesthesia & Analgesia in which researchers at the University of Groningen, the Netherlands, and Ghent University, Belgium, investigated the ability of Masimo ORi to show trends in oxygenation in the moderate hyperoxic region.

27 Aug 2018

Oxygen therapy does not prevent development of heart failure in patients with heart attack

Oxygen therapy does not prevent the development of heart failure. Neither does it reduce the long-term risk of dying for patients with suspected heart attack.

27 Aug 2018

Impaired mental status linked to doubled risk of death after heart attack in elderly patients

Impaired mental status is associated with a doubled risk of death one year after a heart attack in elderly patients, according to research presented today at ESC Congress 2018.

27 Aug 2018

$Entresto drug can be initiated early and safely in heart failure patients with reduced ejection fraction$

Entresto drug can be initiated early and safely in heart failure patients with reduced ejection fraction

Data from the TRANSITION study presented today at the European Society of Cardiology Congress in Munich, Germany has shown that Entresto® can be initiated early and safely in a wide range of heart failure patients with reduced ejection fraction who have been stabilized after hospitalization due to an acute heart failure episode.

25 Aug 2018

Forbius receives $18.75 million grant from CPRIT for Phase 2a development of AVID100

Forbius announced today that it has been awarded a Product Development grant totaling $18.75 million from the Cancer Prevention and Research Institute of Texas.

25 Aug 2018

Patients with blood pressure must start treatment with two drugs as a single pill

A single pill with two drugs could transform blood pressure treatment, according to the 2018 European Society of Cardiology and European Society of Hypertension Guidelines on arterial hypertension published online today in European Heart Journal, and on the ESC website.

25 Aug 2018

Pregnant women with heart disease must give birth at 40 weeks gestation

Pregnant women with heart disease should give birth at no later than 40 weeks gestation. That is one of the recommendations in the 2018 European Society of Cardiology Guidelines for the management of cardiovascular diseases during pregnancy published online today in European Heart Journal, and on the ESC website.

25 Aug 2018

Inhibition of miR-24-3p may serve as potential treatment target for mesothelioma

Inhibition of miR-24-3p reduced growth of cancer cells and was found to regulate proteins as a potential treatment target for Mesothelioma.

25 Aug 2018

Researchers develop new system for effective cancer diagnosis and treatment

A research group consisting of scientists from NUST MISIS, the Technical University of Munich, Helmholtz Zentrum München, the University of Duisburg-Essen, and the University of Oldenburg has developed a system that allows doctors to both improve the accuracy of diagnosing malignant cells and to provide additional opportunities for cancer treatment.

24 Aug 2018

Alternative method identified for delivering nusinersen to spinal muscular atrophy patients

A new report has identified an alternative method to deliver nusinersen to patients with spinal muscular atrophy using a subcutaneous intrathecal catheter system configured by connecting an intrathecal catheter to an implantable infusion port.

24 Aug 2018

Proteins that protect neurons from destruction can be delivered through nose

Protective proteins that mitigate the destruction of nerve cells after a stroke can be administered into the brain through the nose, as Heidelberg University researchers demonstrated using a mouse model.

24 Aug 2018

Therapy News and Research

Use of HIV RNA expression inhibitors restores immune function in HIV patients on cART

UIC receives $7 million for developing programs to prevent adolescent depression

Amphetamine regimen does not improve post-stroke motor recovery

Study shows new options to lower heart disease risk in people with diabetes

New personalized cellular therapy approved for use in the European Union

Antiplatelet monotherapy appears to be safer but does not reduce risk of heart attack

Listening to yoga music before sleep has beneficial impact on heart rate variability

Antithrombin drug does not reduce risk of myocardial infarction, stroke in heart failure patients

Death of Sen. John McCain sheds new light on aggressive brain tumor

Researchers investigate ability of Masimo Ori to show oxygenation trends during moderate hyperoxia

Oxygen therapy does not prevent development of heart failure in patients with heart attack

Impaired mental status linked to doubled risk of death after heart attack in elderly patients

Entresto drug can be initiated early and safely in heart failure patients with reduced ejection fraction

Forbius receives $18.75 million grant from CPRIT for Phase 2a development of AVID100

Patients with blood pressure must start treatment with two drugs as a single pill

Pregnant women with heart disease must give birth at 40 weeks gestation

Inhibition of miR-24-3p may serve as potential treatment target for mesothelioma

Researchers develop new system for effective cancer diagnosis and treatment

Alternative method identified for delivering nusinersen to spinal muscular atrophy patients

Proteins that protect neurons from destruction can be delivered through nose

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News